You are viewing a limited version of this profile. To access i3's full capabilities.
ZeaKal
Save
Company logo (jpg or png)
Parent company

Short description

Developer of plant science technology to improve crop yields

Founded in 2012
Founded in

Company type Private Public ()
Company type

Industry Group agriculture & food

Sector crop inputs

TRL Range 4-6
TRL 1 Basic research
TRL 2 Technology formulation
TRL 3 Applied research
TRL 4 Small scale prototype
TRL 5 Large scale prototype
TRL 6 Prototype system
TRL 7 Demonstration system
TRL 8 First of a kind commercial system
TRL 9 Full commercial application
TRL Range

Ticker

Headquarters San Diego, CA San Diego, United States
Address
City
State
Zip
Country

Parent Companies

Updated by Cleantech Group on 01/03/2020

Traction
  • 0 M&A items
tags
Similar companies
Customers
Save
Date Company
Partnerships
Save
Date Partner Type
02/27/2019
Corteva Agriscience Corteva Agriscience
This partnership is a strategic R&D collaboration. Together, they will advance ZeaKal’s innovative technology to help improve seed quality and increase crop yield by enhancing the photosynthetic capacity and efficiency of plants.
View source    
Confirmed by Corteva Agriscience
Development Partner
Investment Rounds
Save

IPO INFORMATION

Date

IPO status

IPO Type

Amount

Initial shares

Ticker symbol

Exchange listed

Prospectus URL

Prospectus

Source URL

Source

Description

Date Investors Type Amount
06/20/2019 Canopy Rivers Canopy Rivers , Middleland Capital Middleland Capital , Finistere Ventures Finistere Ventures (3)
Post-money valuation of
As a result of its US$10,000,000 investment, Canopy Rivers owns approximately 8.7% of ZeaKal. With multi-year field trials across diverse plant species in the United States, Canada and New Zealand, the initial commercial focus has been on major row crops. Following Canopy Rivers' investment, ZeaKal intends to expand its program to include cannabis and hemp.
Series A $10,000,000
Click to add IPO information
Products
Save
Product image Name Product status Revenue model Cost metrics
You are viewing a limited version of this profile. To access i3's full capabilities.
Back to top

Preload svg text font